Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alper Topal

8PUBLICATIONS
62CO-AUTHORS
Nutrigenomics and personalised nutritionPredictive and prognostic markersPacific Peoples mothers and babies health and wellbeingCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|May 13, 2026
Pre-Transplant Prognostic Nutritional Index Independently Predicts Progression-Free Survival After Autologous Stem Cell Transplantation in Lymphoma.

|Mar 19, 2026
Outcomes of CDK4/6 Inhibitor-Based Therapy in Premenopausal HR+/HER2- Metastatic Breast Cancer: Real World Data From A Multicenter Study.

Hatice Odabaş, Omar Alomari, Seval Orman

|Feb 27, 2026
Medication Adherence in Women with Early-Stage Breast Cancer and Active Parenting Responsibilities: The Mediating Role of Parenting Stress and Spiritual Well-Being.

Veli Çakıcı, Aysel Oğuz, Süleyman Can

|Dec 30, 2025
The Efficacy of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Ewing Sarcoma Patients.

Ömer Faruk Kuzu, Nuri Karadurmuş, Nebi Batuhan Kanat

|Sep 27, 2025
The Impact of Clinical and Morphometric Parameters on Hematopoietic Engraftment Following High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Germ Cell Tumors.

Ömer Faruk Kuzu, Nuri Karadurmuş, Ahmet Gazi Acar

|May 06, 2025
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis.

Sedat Yıldırım, Tugba Başoğlu, Akif Doğan

Pageof 2

Frequent Collaborators

3 joint publications

Ömer Faruk Kuzu

3 joint publications

Musa Barış Aykan

3 joint publications

Sedat Yıldırım

3 joint publications

Hatice Odabas

2 joint publications

Nadiye Sever

2 joint publications

Ayşegül Dumludağ

2 joint publications

Goncagul Akdag

2 joint publications

Oguzcan Kınıkoğlu

2 joint publications

Deniz Işık

2 joint publications

Nargiz Majıdova

Frequent Collaborators

3 joint publications

Ömer Faruk Kuzu

3 joint publications

Musa Barış Aykan

3 joint publications

Sedat Yıldırım

3 joint publications

Hatice Odabas